Stemcell, 200-0720, Human Platelet Lysate, Pathogen-Reduced, GMP-Compliant

Start experiments confidently with a reliable supply of ethically sourced, GMP-compliant, fibrinogen-depleted, and pathogen-reduced human platelet lysate (hPL) for the expansion of cells in vitro. An alternative to fetal bovine serum (FBS), this growth factor-rich cell culture supplement is derived from healthy donor human platelets, and multiple donor units are pooled during manufacturing to minimize lot-to-lot variability. Heparin is not added during the manufacturing process and is not required for use of this product. An electron beam (e-beam) irradiation step is included in the manufacturing process for pathogen reduction.

hPL is sourced from U.S. Food and Drug Administration (FDA)-registered, AABB-certified blood banks in the United States.

Consent is obtained from volunteers participating in a donor collection program that is reviewed and/or approved by either an Institutional Review Board (IRB), the U.S. FDA, U.S. Department of Health and Human Services, and/or an equivalent regulatory authority.

Certain products are only available in select territories. Please contact your sales representative or Product & Scientific Support at [email protected] for further information.

Browse Frequently Asked Questions (FAQs) on Primary Cells.